The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy
Abstract
Purpose A substantial proportion of breast cancer survivors report significant, long-lasting impairments in cognitive function, often referred to as "chemobrain." Advances in detection and treatment mean that many more patients are surviving long-term following diagnosis of invasive breast cancer. Thus, it is important to define the types, extent, and persistence of cognitive impairments following treatment with cytotoxic cancer drugs. Experimental design We examined the effects of chronic treatment with two agents commonly used in patients with breast cancer, cyclophosphamide and doxorubicin (Adriamycin). Athymic nude rats were given 50 mg/kg cyclophosphamide, 2 mg/kg doxorubicin, or saline injections once per week for 4 weeks. A novel place recognition task and contextual and cued fear conditioning were used to characterize learning and memory ability. Immunofluorescence staining for immature and mature neurons and activated microglia was used to assess changes in neurogenesis and neuroinflammation. Results Cyclophosphamide- and doxorubicin-treated rats showed significantly impaired performance on the novel place recognition task and the contextual fear conditioning task compared with untreated controls, suggesting disrupted hippocampal-based memory function. Chemotherapy-treated animals showed a significant decline in neurogenesis [80%-90% drop in bromodeoxyuridine (BrdUrd)-labeled cells expressing NeuN]. Activated microglia (ED1-positive) were found after cyclophosphamide…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Humans receiving chemotherapy, which kills proliferating cells (thus blunting neurogenesis), experience cognitive deficits and are more likely to develop depression than cancer patients treated with other therapies128-130.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [130]
Citations
Cites
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.
Phillips, R. G., & LeDoux, J. E. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.2.274 · Cited by 3,292 · cited 4×
“indicating intact acquisition and memory for the conditioned tone stimulus, which has been shown to rely on intact amygdala function (36).”
BackgroundInfluentialSaxe, M. D., Battaglia, F., Wang, J.-W., Malleret, G., David, D. J., Monckton, J. E., Garcia, A. D. R., Sofroniew, M. V., Kandel, E. R., Santarelli, L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607207103 · Cited by 1,020
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70294-1 · Cited by 998
Kempermann, G., Gast, D., Kronenberg, G., Yamaguchi, M., & Gage, F. H. (2003) · Development · doi:10.1242/dev.00203 · Cited by 983 · cited 1×
“neuronal lineage and remain stable from approximately 12 to 14 days (37).”
BackgroundP-Glycoprotein, a gatekeeper in the blood–brain barrier
Schinkel, A. H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00085-4 · Cited by 960
Candidate mechanisms for chemotherapy-induced cognitive changes
Ahles, T. A., & Saykin, A. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2073 · Cited by 916
van Dam, F. S. A. M., Boogerd, W., Schagen, S. B., Muller, M. J., Droogleever Fortuyn, M. E., Wall, E. V. D., & Rodenhuis, S. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.210 · Cited by 763 · cited 5×
“Subsequent individual oneway ANOVAs conducted for each phase of the task revealed a significant group effect for the context test phase of the fear conditioning task only [F(2,24) 1⁄4 11.”
BackgroundMethodInfluentialAhles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.485 · Cited by 736 · cited 1×
“8), whether mild or severe, are lasting and have a major negative impact on quality of life (4, 25, 26).”
BackgroundHippocampal damage and exploratory preferences in rats: memory for objects, places, and contexts
Mumby, D. G., Gaskin, S., Glenn, M. J., Schramek, T. E., & Lehmann, H. (2002) · Learning & Memory · doi:10.1101/lm.41302 · Cited by 714
Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20272 · Cited by 679
Cited by
Lange, M., Joly, F., Vardy, J., Ahles, T., Dubois, M., Tron, L., Winocur, G., De Ruiter, M. B., & Castel, H. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz410 · Cited by 667
“Indeed, cyclophosphamide, doxorubicin, and 5-fluorouracil prevent the production of new cells in the hippocampus, and suppression of neurogenesis is directly related to accompanying loss of hippocampus-dependent cognitive functions [32, 39].”
BackgroundLong-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species
Montay-Gruel, P., Acharya, M. M., Petersson, K., Alikhani, L., Yakkala, C., Allen, B. D., Ollivier, J., Petit, B., Jorge, P. G., Syage, A. R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901777116 · Cited by 599
“Fear extinction follows a modified fear conditioning protocol (54) in which repeated trials dissociating the tone-shock pairing can be used to measure the rate of reduced freezing or fear extinction.”
BackgroundSelf-citationTartt, A. N., Mariani, M. B., Hen, R., Mann, J. J., & Boldrini, M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01520-y · Cited by 408
“In rodents, administration of chemotherapy resulted in a loss of hippocampal proliferating cells that correlated with behavioral deficits [130, 131].”
BackgroundMechanisms of Chemotherapy-Induced Neurotoxicity
Was, H., Borkowska, A., Bagues, A., Tu, L., Liu, J. Y. H., Lu, Z., Rudd, J. A., Nurgali, K., & Abalo, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.750507 · Cited by 285
“Therefore, suppression of neurogenesis was directly related to chronic neurotoxic effects, including hippocampusdependent cognitive functions (Christie et al., 2012; Monje and Dietrich, 2012; Lomeli et al., 2017).”
BackgroundCancer-treatment-induced neurotoxicity—focus on newer treatments
Stone, J. B., & DeAngelis, L. M. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.152 · Cited by 274
Metadata
- Authors
- Christie, L.-A., Acharya, M. M., Parihar, V. K., Nguyen, A., Martirosian, V., & Limoli, C. L.
- Affiliations
- University of California, Irvine (US)
- Venue
- Clinical Cancer Research
- Published
- 2012-04-01
- Volume
- 18
- Issue
- 7
- Pages
- 1954-1965
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2102451894
- Cited by
- 311
- References
- 45
- Citations by year
- 2026: 20 · 2025: 22 · 2024: 24 · 2023: 21 · 2022: 23 · 2021: 38 · 2020: 26 · 2019: 19 · 2018: 17 · 2017: 24 · 2016: 23 · 2015: 16 · 2014: 17 · 2013: 15 · 2012: 6
- FWCI
- 13.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Directorate for Biological Sciences
- U.S. Public Health Service (U19A1067769)
- University of California, Irvine
- National Institute of Allergy and Infectious Diseases
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- chemobrain, chemotherapy-induced cognitive impairment, breast cancer, cyclophosphamide, doxorubicin, hippocampal neurogenesis, neuroinflammation, microglial activation, fear conditioning, learning and memory, long-term cancer survivors
- MeSH terms
- Analysis of Variance, Animals, Antineoplastic Agents, Body Weight, Breast Neoplasms, Bromodeoxyuridine, Cognition Disorders, Conditioning, Psychological, Cyclophosphamide, Doxorubicin, Fear, Female, Fluorescent Antibody Technique, Hippocampus, Humans, Learning, Male, Memory, Motor Activity, Neurons, Rats, Nude, Rats, Neurogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-11-2000
- The paper
- Christie, L.-A., Acharya, M. M., Parihar, V. K., Nguyen, A., Martirosian, V., & Limoli, C. L. (2012). Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-11-2000
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.